Recently, in a murine cardiovascular model, SERPINA3 was found to be upregulated and in a population of cancer survivors with CTRCD (LVEF < 50%), on average 5 years after AnC, SERPINA3 values were increased compared to an age and sex-matched control population [10]. The gene discussed is SERPINA3; the disease is cancer.